Host-Targeted Perturbations for Eradication of Recalcitrant Salmonella Infections

Grant number: 226546/Z/22/Z

Grant search

Key facts

  • Disease

    Salmonella infection
  • Start & end year

    2023
    2031
  • Known Financial Commitments (USD)

    $4,308,922.01
  • Funder

    Wellcome Trust
  • Principal Investigator

    Peter Hill
  • Research Location

    United Kingdom
  • Lead Research Institution

    King's College London
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Salmonella is defined as a WHO-priority pathogen due to rising antimicrobial resistance. During antibiotic treatment, reservoirs of invasive non-typhoidal Salmonella capable of seeding infection relapse (called persisters) survive within macrophages. Eradication of persisters is challenging, necessitating sustained inflammation that can exacerbate Salmonella infection-associated pathology. Therapeutic technologies precisely modulating expression of individual genes in innate immune cells raise the possibility of controllably tuning macrophage phenotype for safe eradication of persisters. It remains unclear, however, how exactly this can be achieved. Here, we aim to identify host-directed perturbations enabling Salmonella persister eradication in the clinic. Focussing on host transcription factors and chromatin regulators, we will first identify and characterise candidate loss-of-function and gain-of- function perturbations redirecting persister-infected macrophage transcriptional networks to favour persister clearance. We will then use causal deep learning approaches and clinical data to determine which candidate perturbations are most likely to have therapeutic impact in patients undergoing antibiotic treatment for non-typhoidal Salmonella disease. In later years, we will extend our research to other bacterial infections where macrophage-resident persisters are similarly associated with infection relapse (Salmonella Typhi, Mycobacterium tuberculosis, Staphylococcus aureus). Collectively, we anticipate that our research will pave the way for development of next-generation antibacterial immunotherapies to eradicate recalcitrant infections.

Publicationslinked via Europe PMC

Salmonella Effector SteE Reprogrammes the Macrophage Regulatory Network to Drive Specific Hyperactivation of STAT3 Target Genes